2,252
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Improvement in clinical disease activity index when treatment selection is informed by the tumor necrosis factor-ɑ inhibitor molecular signature response classifier: analysis from the study to accelerate information of molecular signatures in rheumatoid arthritis

, , , , & ORCID Icon
Pages 801-807 | Received 27 Feb 2022, Accepted 13 Apr 2022, Published online: 23 Apr 2022

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Jeffrey R. Curtis, Vibeke Strand, Steven Golombek, Lixia Zhang, Angus Wong, Mark C. Zielinski, Viatcheslav R. Akmaev, Alif Saleh, Sam Asgarian & Johanna B. Withers. (2022) Patient outcomes improve when a molecular signature test guides treatment decision-making in rheumatoid arthritis. Expert Review of Molecular Diagnostics 22:10, pages 973-982.
Read now